| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 2.76e-05 | 38 | 92 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 5.94e-05 | 46 | 92 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A4 GJA1 SLC6A11 CACNA1S CACNA2D1 SFXN5 SLC11A1 TRPC1 SCNN1A ABCC9 ATP13A5 PKDREJ CHRND | 6.82e-05 | 793 | 92 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.86e-04 | 343 | 92 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.16e-04 | 118 | 92 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A4 SLC6A11 CACNA1S CACNA2D1 SLC11A1 TRPC1 SCNN1A ABCC9 ATP13A5 PKDREJ CHRND | 2.36e-04 | 664 | 92 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A4 SLC6A11 CACNA1S CACNA2D1 SLC11A1 TRPC1 SCNN1A ABCC9 PKDREJ | 2.93e-04 | 465 | 92 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 3.11e-04 | 6 | 92 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 5.77e-04 | 8 | 92 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | channel activity | SLC6A4 GJA1 CACNA1S CACNA2D1 TRPC1 SCNN1A ABCC9 PKDREJ CHRND | 7.04e-04 | 525 | 92 | 9 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC6A4 GJA1 CACNA1S CACNA2D1 TRPC1 SCNN1A ABCC9 PKDREJ CHRND | 7.13e-04 | 526 | 92 | 9 | GO:0022803 |
| GeneOntologyMolecularFunction | endopeptidase activity | 8.32e-04 | 430 | 92 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A4 GJA1 SLC6A11 CACNA1S CACNA2D1 SFXN5 SLC11A1 SLCO2B1 TRPC1 SCNN1A ABCC9 ATP13A5 PKDREJ CHRND | 9.78e-04 | 1180 | 92 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.26e-03 | 459 | 92 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | integrin binding | 1.30e-03 | 175 | 92 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.78e-03 | 188 | 92 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A4 GJA1 SLC6A11 CACNA1S CACNA2D1 SFXN5 SLC11A1 SLCO2B1 TRPC1 SCNN1A ABCC9 ATP13A5 PKDREJ CHRND | 2.25e-03 | 1289 | 92 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.31e-03 | 120 | 92 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A4 SLC6A11 CACNA1S CACNA2D1 SLC11A1 TRPC1 SCNN1A ABCC9 PKDREJ | 2.40e-03 | 627 | 92 | 9 | GO:0022890 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.90e-05 | 12 | 93 | 3 | GO:0038063 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A3 COL4A5 ORM2 EFEMP1 ADAMTS3 L1CAM NAV2 ADAMTS18 NCAM1 COL5A3 MUC5B ADAMTSL3 USH2A SVEP1 | 2.25e-07 | 656 | 94 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A3 COL4A5 ORM2 EFEMP1 ADAMTS3 L1CAM NAV2 ADAMTS18 NCAM1 COL5A3 MUC5B ADAMTSL3 USH2A SVEP1 | 2.34e-07 | 658 | 94 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.74e-06 | 6 | 94 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.16e-06 | 21 | 94 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 4.85e-06 | 8 | 94 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 4.85e-06 | 8 | 94 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 4.85e-06 | 8 | 94 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A3 COL4A5 ORM2 EFEMP1 ADAMTS3 L1CAM NAV2 NCAM1 COL5A3 USH2A | 2.59e-05 | 530 | 94 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | myosin complex | 1.44e-04 | 59 | 94 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | basement membrane | 2.26e-04 | 122 | 94 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen trimer | 6.70e-04 | 88 | 94 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.28e-03 | 12 | 94 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | postsynapse | SLC6A4 SLC6A11 CACNA1S CACNA2D1 NRCAM FCGR2A MYO9A MYO9B WASF3 NCAM1 USP48 CHRND | 2.01e-03 | 1018 | 94 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.35e-03 | 405 | 94 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A1 COL4A3 COL4A5 GJA1 DNAI1 CACNA1S MYO9A MYO9B TRPC1 NAV3 ABCC9 COL5A3 TTLL8 | 2.48e-03 | 1187 | 94 | 13 | GO:0099081 |
| Domain | C4 | 2.29e-06 | 6 | 92 | 3 | SM00111 | |
| Domain | - | 2.29e-06 | 6 | 92 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.29e-06 | 6 | 92 | 3 | IPR001442 | |
| Domain | C4 | 2.29e-06 | 6 | 92 | 3 | PF01413 | |
| Domain | NC1_IV | 2.29e-06 | 6 | 92 | 3 | PS51403 | |
| Domain | IQ | 2.62e-05 | 71 | 92 | 5 | PF00612 | |
| Domain | Myosin_head_motor_dom | 3.58e-05 | 38 | 92 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.58e-05 | 38 | 92 | 4 | PS51456 | |
| Domain | Myosin_head | 3.58e-05 | 38 | 92 | 4 | PF00063 | |
| Domain | MYSc | 3.58e-05 | 38 | 92 | 4 | SM00242 | |
| Domain | IQ | 4.96e-05 | 81 | 92 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 8.21e-05 | 90 | 92 | 5 | IPR000048 | |
| Domain | IQ | 9.60e-05 | 93 | 92 | 5 | PS50096 | |
| Domain | PLAC | 1.06e-04 | 19 | 92 | 3 | PS50900 | |
| Domain | PLAC | 1.06e-04 | 19 | 92 | 3 | IPR010909 | |
| Domain | Neurofascin/L1/NrCAM_C | 1.43e-04 | 4 | 92 | 2 | IPR026966 | |
| Domain | Lys_sp_deMease-like_dom | 1.43e-04 | 4 | 92 | 2 | IPR013637 | |
| Domain | PLU-1 | 1.43e-04 | 4 | 92 | 2 | PF08429 | |
| Domain | Bravo_FIGEY | 1.43e-04 | 4 | 92 | 2 | PF13882 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.17e-04 | 24 | 92 | 3 | IPR013273 | |
| Domain | zf-C5HC2 | 2.38e-04 | 5 | 92 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 2.38e-04 | 5 | 92 | 2 | IPR004198 | |
| Domain | TIG | 4.70e-04 | 31 | 92 | 3 | PF01833 | |
| Domain | IPT | 5.17e-04 | 32 | 92 | 3 | IPR002909 | |
| Domain | Collagen | 8.23e-04 | 85 | 92 | 4 | IPR008160 | |
| Domain | Collagen | 8.23e-04 | 85 | 92 | 4 | PF01391 | |
| Domain | Peptidase_M12B_N | 9.30e-04 | 39 | 92 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 9.30e-04 | 39 | 92 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.00e-03 | 40 | 92 | 3 | PS00427 | |
| Domain | Reprolysin | 1.00e-03 | 40 | 92 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.00e-03 | 40 | 92 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.00e-03 | 40 | 92 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.00e-03 | 40 | 92 | 3 | IPR001590 | |
| Domain | JmjN | 1.05e-03 | 10 | 92 | 2 | SM00545 | |
| Domain | JMJN | 1.05e-03 | 10 | 92 | 2 | PS51183 | |
| Domain | JmjN | 1.05e-03 | 10 | 92 | 2 | PF02375 | |
| Domain | JmjN | 1.05e-03 | 10 | 92 | 2 | IPR003349 | |
| Domain | Disintegrin_dom | 1.08e-03 | 41 | 92 | 3 | IPR001762 | |
| Domain | fn3 | 1.24e-03 | 162 | 92 | 5 | PF00041 | |
| Domain | ZINC_PROTEASE | 1.40e-03 | 98 | 92 | 4 | PS00142 | |
| Domain | - | PLXNA3 NRCAM FCGR2A L1CAM NCAM1 REL CAMTA1 ADAMTSL3 USH2A IL6ST | 1.56e-03 | 663 | 92 | 10 | 2.60.40.10 |
| Domain | CTDL_fold | 1.93e-03 | 107 | 92 | 4 | IPR016187 | |
| Domain | PLAC | 2.10e-03 | 14 | 92 | 2 | PF08686 | |
| Domain | FN3 | 2.22e-03 | 185 | 92 | 5 | SM00060 | |
| Domain | - | 2.42e-03 | 15 | 92 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 2.42e-03 | 15 | 92 | 2 | SM00501 | |
| Domain | ARID_dom | 2.42e-03 | 15 | 92 | 2 | IPR001606 | |
| Domain | ARID | 2.42e-03 | 15 | 92 | 2 | PS51011 | |
| Domain | ARID | 2.42e-03 | 15 | 92 | 2 | PF01388 | |
| Domain | Ig-like_fold | PLXNA3 NRCAM FCGR2A L1CAM NCAM1 REL CAMTA1 ADAMTSL3 USH2A IL6ST | 2.47e-03 | 706 | 92 | 10 | IPR013783 |
| Domain | FN3 | 3.04e-03 | 199 | 92 | 5 | PS50853 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.49e-03 | 18 | 92 | 2 | PS00754 | |
| Domain | TSP_1 | 3.71e-03 | 63 | 92 | 3 | PF00090 | |
| Domain | FN3_dom | 3.74e-03 | 209 | 92 | 5 | IPR003961 | |
| Domain | SNF | 3.89e-03 | 19 | 92 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 3.89e-03 | 19 | 92 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 3.89e-03 | 19 | 92 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 3.89e-03 | 19 | 92 | 2 | IPR000175 | |
| Domain | TSP1 | 4.05e-03 | 65 | 92 | 3 | SM00209 | |
| Domain | TSP1_rpt | 4.05e-03 | 65 | 92 | 3 | IPR000884 | |
| Domain | TSP1 | 4.05e-03 | 65 | 92 | 3 | PS50092 | |
| Domain | - | 4.74e-03 | 21 | 92 | 2 | 1.10.720.30 | |
| Domain | - | 4.83e-03 | 222 | 92 | 5 | 1.25.10.10 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.49e-08 | 42 | 70 | 6 | M7169 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.55e-07 | 63 | 70 | 6 | M11187 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.54e-06 | 20 | 70 | 4 | MM15061 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.60e-06 | 23 | 70 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.60e-06 | 23 | 70 | 4 | MM1427 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.25e-05 | 61 | 70 | 5 | MM14637 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.37e-05 | 10 | 70 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.37e-05 | 10 | 70 | 3 | MM1560 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A3 COL4A5 EFEMP1 ADAMTS3 ADAMTS18 NCAM1 COL5A3 KLKB1 | 1.65e-05 | 300 | 70 | 9 | M610 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.80e-05 | 32 | 70 | 4 | MM14924 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.88e-05 | 11 | 70 | 3 | M15422 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.99e-05 | 67 | 70 | 5 | M26999 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A1 CUL2 COL4A3 PLXNA3 COL4A5 CACNA1S NRCAM MYO9B TRPC1 L1CAM NCAM1 COL5A3 | 2.31e-05 | 575 | 70 | 12 | M29853 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.50e-05 | 12 | 70 | 3 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.24e-05 | 13 | 70 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.24e-05 | 13 | 70 | 3 | M12950 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.62e-05 | 38 | 70 | 4 | MM14969 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.67e-05 | 76 | 70 | 5 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.67e-05 | 76 | 70 | 5 | MM14573 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 4.10e-05 | 14 | 70 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 4.10e-05 | 14 | 70 | 3 | M6487 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.91e-05 | 41 | 70 | 4 | MM15538 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.11e-05 | 15 | 70 | 3 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.11e-05 | 15 | 70 | 3 | M27161 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 5.94e-05 | 43 | 70 | 4 | M53 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 6.51e-05 | 44 | 70 | 4 | M27812 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.70e-05 | 140 | 70 | 6 | M587 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.28e-05 | 90 | 70 | 5 | M631 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.07e-05 | 18 | 70 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.07e-05 | 18 | 70 | 3 | MM14882 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.08e-04 | 50 | 70 | 4 | MM14796 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.26e-04 | 20 | 70 | 3 | M15394 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.36e-04 | 53 | 70 | 4 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.81e-04 | 57 | 70 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.93e-04 | 58 | 70 | 4 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.07e-04 | 59 | 70 | 4 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.35e-04 | 61 | 70 | 4 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.52e-04 | 114 | 70 | 5 | MM14571 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.83e-04 | 64 | 70 | 4 | M26953 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.57e-04 | 68 | 70 | 4 | M27303 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.32e-04 | 30 | 70 | 3 | M27216 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.46e-04 | 76 | 70 | 4 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.34e-04 | 85 | 70 | 4 | M16441 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.43e-04 | 39 | 70 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.43e-04 | 39 | 70 | 3 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.49e-03 | 250 | 70 | 6 | M27554 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.53e-03 | 46 | 70 | 3 | M198 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.75e-03 | 258 | 70 | 6 | MM14572 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.85e-03 | 261 | 70 | 6 | MM15676 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.10e-03 | 109 | 70 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.24e-03 | 111 | 70 | 4 | M27416 | |
| Pathway | WP_8P231_COPY_NUMBER_VARIATION_SYNDROME | 2.43e-03 | 54 | 70 | 3 | M48073 | |
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 1.91e-08 | 3 | 94 | 3 | 34049963 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 7706555 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 11807022 | ||
| Pubmed | 2.89e-07 | 21 | 94 | 4 | 23325811 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 2426947 | ||
| Pubmed | Expression of connexins in the developing olfactory system of the mouse. | 3.80e-07 | 6 | 94 | 3 | 1332989 | |
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 3.80e-07 | 6 | 94 | 3 | 10534397 | |
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 3.80e-07 | 6 | 94 | 3 | 19275937 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 3.80e-07 | 6 | 94 | 3 | 9506531 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 7495302 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 3.80e-07 | 6 | 94 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 3.80e-07 | 6 | 94 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 3.80e-07 | 6 | 94 | 3 | 6389236 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 12225806 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 3.80e-07 | 6 | 94 | 3 | 9673377 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 11732842 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 6.64e-07 | 7 | 94 | 3 | 8006028 | |
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 6.64e-07 | 7 | 94 | 3 | 10716744 | |
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 7521231 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 17418794 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 10639489 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 11711546 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 11212352 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 1724753 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 1377218 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.06e-06 | 8 | 94 | 3 | 10970885 | |
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 3997552 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 29422532 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 1383086 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 10382266 | ||
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 8562707 | ||
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 12101409 | ||
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 9878537 | ||
| Pubmed | 2.26e-06 | 10 | 94 | 3 | 9415455 | ||
| Pubmed | 2.26e-06 | 10 | 94 | 3 | 9136074 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.11e-06 | 11 | 94 | 3 | 7500359 | |
| Pubmed | 3.11e-06 | 11 | 94 | 3 | 14998921 | ||
| Pubmed | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | 3.11e-06 | 11 | 94 | 3 | 17339318 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.11e-06 | 11 | 94 | 3 | 9731539 | |
| Pubmed | 4.13e-06 | 12 | 94 | 3 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 4.13e-06 | 12 | 94 | 3 | 15837576 | |
| Pubmed | 4.13e-06 | 12 | 94 | 3 | 16024816 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 4.13e-06 | 12 | 94 | 3 | 12180907 | |
| Pubmed | 4.13e-06 | 12 | 94 | 3 | 19396169 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A1 PLXNA3 COL4A5 GJA1 CACNA2D1 FAM234A EFEMP1 HNRNPUL2 FDFT1 XPO6 L1CAM USP48 IL6ST DMXL1 | 4.22e-06 | 1201 | 94 | 14 | 35696571 |
| Pubmed | 4.24e-06 | 40 | 94 | 4 | 27068110 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 5.36e-06 | 13 | 94 | 3 | 9833687 | |
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 5.36e-06 | 13 | 94 | 3 | 24559674 | |
| Pubmed | 6.57e-06 | 257 | 94 | 7 | 16335952 | ||
| Pubmed | 6.81e-06 | 14 | 94 | 3 | 12878203 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 6.86e-06 | 97 | 94 | 5 | 27559042 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15022265 | ||
| Pubmed | PUM2 regulates the formation of thoracic aortic dissection through EFEMP1. | 7.23e-06 | 2 | 94 | 2 | 37062520 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 18081712 | ||
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 7.23e-06 | 2 | 94 | 2 | 10441747 | |
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 7.23e-06 | 2 | 94 | 2 | 16416087 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26990843 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 32081420 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21143337 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23303673 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 22723769 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 1723996 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8509458 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 18972120 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 7524912 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15583824 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 11564762 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20614160 | ||
| Pubmed | Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility. | 7.23e-06 | 2 | 94 | 2 | 32252656 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 32451867 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 35177655 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 34400539 | ||
| Pubmed | Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations. | 7.23e-06 | 2 | 94 | 2 | 30661074 | |
| Pubmed | L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets. | 7.23e-06 | 2 | 94 | 2 | 26478212 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 16688529 | ||
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 7.23e-06 | 2 | 94 | 2 | 9060413 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 16940319 | ||
| Pubmed | Guidelines for Genetic Testing and Management of Alport Syndrome. | 7.23e-06 | 2 | 94 | 2 | 34930753 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8071656 | ||
| Pubmed | Homophilic NCAM interactions interfere with L1 stimulated neurite outgrowth. | 7.23e-06 | 2 | 94 | 2 | 10611478 | |
| Pubmed | Discordance between skin biopsy and kidney biopsy in an X-linked carrier of Alport syndrome. | 7.23e-06 | 2 | 94 | 2 | 17294221 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 1894011 | ||
| Pubmed | 8.50e-06 | 15 | 94 | 3 | 10625553 | ||
| Pubmed | 8.50e-06 | 15 | 94 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 8.50e-06 | 15 | 94 | 3 | 10706142 | |
| Pubmed | 1.04e-05 | 16 | 94 | 3 | 15878328 | ||
| Pubmed | 1.51e-05 | 18 | 94 | 3 | 9160753 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 1.69e-05 | 198 | 94 | 6 | 20881960 | |
| Pubmed | 1.80e-05 | 19 | 94 | 3 | 15689378 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 2.16e-05 | 3 | 94 | 2 | 27576055 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 14676276 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 3025878 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24522496 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 6386565 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 7962065 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 28704582 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 21187373 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 2.16e-05 | 3 | 94 | 2 | 30647093 | |
| Interaction | OSM interactions | 1.86e-06 | 20 | 92 | 4 | int:OSM | |
| GeneFamily | Myosins, class IX | 1.56e-05 | 2 | 72 | 2 | 1103 | |
| GeneFamily | Collagens | 3.32e-05 | 46 | 72 | 4 | 490 | |
| GeneFamily | Fibronectin type III domain containing | 4.42e-04 | 160 | 72 | 5 | 555 | |
| GeneFamily | AT-rich interaction domain containing | 1.59e-03 | 15 | 72 | 2 | 418 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.56e-03 | 19 | 72 | 2 | 50 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.90e-03 | 161 | 72 | 4 | 593 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 4.08e-03 | 24 | 72 | 2 | 485 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.78e-03 | 26 | 72 | 2 | 253 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | COL4A5 MRC1 GJA1 EFEMP1 FCGR2A SLCO2B1 WASF3 NAV3 ADAMTSL3 KLKB1 | 1.17e-06 | 382 | 94 | 10 | M45756 |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 GJA1 CACNA2D1 EFEMP1 WASF3 NAV3 NAV2 COL5A3 ARMCX2 ADAMTSL3 SVEP1 IL6ST SMAD9 | 3.54e-06 | 767 | 94 | 13 | M39209 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.28e-05 | 40 | 94 | 4 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 PLXNA3 COL4A5 EFEMP1 ADAMTS3 ADAM20 ADAMTS18 COL5A3 CST7 MUC5B ADAMTSL3 USH2A SVEP1 | 1.71e-05 | 1026 | 94 | 14 | M5889 |
| Coexpression | NABA_COLLAGENS | 1.72e-05 | 43 | 94 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.89e-05 | 44 | 94 | 4 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | 6.10e-05 | 275 | 94 | 7 | M5884 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 PLXNA3 COL4A5 EFEMP1 ADAMTS3 ADAM20 ADAMTS18 COL5A3 CST7 MUC5B ADAMTSL3 SVEP1 | 6.27e-05 | 1008 | 94 | 13 | MM17056 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 7.51e-05 | 23 | 94 | 3 | M48001 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 8.08e-05 | 198 | 94 | 6 | M8624 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN | 8.54e-05 | 200 | 94 | 6 | M7993 | |
| Coexpression | HALLMARK_ESTROGEN_RESPONSE_EARLY | 8.54e-05 | 200 | 94 | 6 | M5906 | |
| Coexpression | AIZARANI_LIVER_C2_KUPFFER_CELLS_1 | 8.54e-05 | 200 | 94 | 6 | M39106 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | 1.01e-04 | 402 | 94 | 8 | M45754 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | COL4A1 MRC1 SLC11A1 ADAMTS3 FCGR2A MYO9B SLCO2B1 ACOT9 LRSAM1 L1CAM SCNN1A ARMCX2 KLKB1 SVEP1 | 1.34e-04 | 1242 | 94 | 14 | M1920 |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 1.47e-04 | 221 | 94 | 6 | M15835 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 1.74e-05 | 125 | 92 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.71e-05 | 211 | 92 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.08e-09 | 184 | 93 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.31e-09 | 185 | 93 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.54e-09 | 190 | 93 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.54e-08 | 175 | 93 | 7 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.96e-08 | 179 | 93 | 7 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-07 | 181 | 93 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-07 | 184 | 93 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-07 | 184 | 93 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-07 | 186 | 93 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.49e-07 | 190 | 93 | 7 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.66e-07 | 193 | 93 | 7 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-07 | 194 | 93 | 7 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-07 | 195 | 93 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 196 | 93 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 196 | 93 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-07 | 196 | 93 | 7 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.05e-07 | 199 | 93 | 7 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-07 | 200 | 93 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 167 | 93 | 6 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 167 | 93 | 6 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-06 | 173 | 93 | 6 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-06 | 177 | 93 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-06 | 182 | 93 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.30e-06 | 182 | 93 | 6 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.37e-06 | 183 | 93 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 185 | 93 | 6 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.60e-06 | 186 | 93 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-06 | 187 | 93 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.69e-06 | 187 | 93 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 2.77e-06 | 188 | 93 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 189 | 93 | 6 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | EC-Sinusoidal_ECs|World / Lineage and Cell class | 2.86e-06 | 189 | 93 | 6 | 9a0956c8a7069ba3bd0fa56d052d6e514453e578 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 189 | 93 | 6 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 189 | 93 | 6 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 189 | 93 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 190 | 93 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 190 | 93 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 190 | 93 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 2.94e-06 | 190 | 93 | 6 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 191 | 93 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 3.03e-06 | 191 | 93 | 6 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 191 | 93 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 191 | 93 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.03e-06 | 191 | 93 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.03e-06 | 191 | 93 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.13e-06 | 192 | 93 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-06 | 193 | 93 | 6 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-06 | 193 | 93 | 6 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-06 | 193 | 93 | 6 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | EC-Sinusoidal_ECs|EC / Lineage and Cell class | 3.22e-06 | 193 | 93 | 6 | 1291b1d3494dcb4b9309f8bff63fb662e7eca0c8 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.22e-06 | 193 | 93 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-06 | 193 | 93 | 6 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-06 | 194 | 93 | 6 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-06 | 194 | 93 | 6 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 3.52e-06 | 196 | 93 | 6 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.63e-06 | 197 | 93 | 6 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.73e-06 | 198 | 93 | 6 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.73e-06 | 198 | 93 | 6 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.84e-06 | 199 | 93 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.84e-06 | 199 | 93 | 6 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.84e-06 | 199 | 93 | 6 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.84e-06 | 199 | 93 | 6 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.84e-06 | 199 | 93 | 6 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | medial-mesenchymal-Pericyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | bbda454260016be92b539e220ecf7bcbbc6139e4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.96e-06 | 200 | 93 | 6 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.96e-06 | 200 | 93 | 6 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.96e-06 | 200 | 93 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | medial-mesenchymal-Pericyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | f36d7cb6345daccebf76997f998e35d959b59452 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.96e-06 | 200 | 93 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | 313ec1e53bd738a9cb48dc5b946261156f99f44b | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.96e-06 | 200 | 93 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | medial-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | 9820fb4f6efcdfc6de937ef2302a98b48426baa3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-06 | 200 | 93 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT1|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.96e-06 | 200 | 93 | 6 | b746dcc94814bcbca63c71e6451a9c5f084bcfaf | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.96e-06 | 200 | 93 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.96e-06 | 200 | 93 | 6 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d | |
| ToppCell | distal-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-06 | 200 | 93 | 6 | 4ee0b2f56c2652435fa78bf6b3c90cea28df74e0 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-05 | 155 | 93 | 5 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 2.09e-05 | 159 | 93 | 5 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-05 | 162 | 93 | 5 | 0acb8f7b51bf422d4f4f8e99bd10360163ae4eb7 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.73e-05 | 168 | 93 | 5 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-05 | 169 | 93 | 5 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-05 | 170 | 93 | 5 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.97e-05 | 171 | 93 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.05e-05 | 85 | 93 | 4 | 7c5ea38893372fdecf7cc3ccf46a37b4ec45f0b1 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.05e-05 | 85 | 93 | 4 | 5a2c02aeceeabd44a417b09ac8b2e2f185070b15 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.05e-05 | 85 | 93 | 4 | 0bfabb6761a84d6a04f9fa415106a33059d78099 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.05e-05 | 172 | 93 | 5 | 68fd03f2c8ee01fe46194400f74ede3830e00f34 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.05e-05 | 172 | 93 | 5 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.05e-05 | 172 | 93 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 174 | 93 | 5 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-05 | 175 | 93 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 176 | 93 | 5 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.40e-05 | 176 | 93 | 5 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 176 | 93 | 5 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 177 | 93 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 3.50e-05 | 177 | 93 | 5 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| Drug | AC1NPPZW | 2.17e-07 | 103 | 93 | 7 | CID005183170 | |
| Drug | S-(-)-Etomoxir | 3.45e-06 | 100 | 93 | 6 | CID000060765 | |
| Drug | Benzethonium chloride [121-54-0]; Up 200; 9uM; HL60; HT_HG-U133A | 1.54e-05 | 195 | 93 | 7 | 2508_UP | |
| Drug | sipatrigine | 1.55e-05 | 37 | 93 | 4 | CID000060803 | |
| Drug | furosemide | 1.59e-05 | 272 | 93 | 8 | CID000003440 | |
| Drug | SM-6586 | 1.65e-05 | 2 | 93 | 2 | CID005487142 | |
| Drug | diazipine | 1.65e-05 | 2 | 93 | 2 | CID000195792 | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.70e-05 | 198 | 93 | 7 | 6487_UP | |
| Disease | collagen disease (implicated_via_orthology) | 3.93e-08 | 12 | 90 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Alport syndrome (is_implicated_in) | 2.75e-05 | 3 | 90 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Alport syndrome | 2.75e-05 | 3 | 90 | 2 | cv:C1567741 | |
| Disease | adenoma (is_marker_for) | 2.75e-05 | 3 | 90 | 2 | DOID:657 (is_marker_for) | |
| Disease | Collagen IV-related nephropathies | 2.75e-05 | 3 | 90 | 2 | cv:CN076135 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 3.94e-05 | 62 | 90 | 4 | DOID:9074 (is_implicated_in) | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 5.50e-05 | 4 | 90 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Hematuria, Benign Familial | 5.50e-05 | 4 | 90 | 2 | C0241908 | |
| Disease | Alport Syndrome | 5.50e-05 | 4 | 90 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 9.15e-05 | 5 | 90 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 9.15e-05 | 5 | 90 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 9.15e-05 | 5 | 90 | 2 | C1567744 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.05e-04 | 152 | 90 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Marijuana Abuse | 1.05e-04 | 30 | 90 | 3 | C0024809 | |
| Disease | dengue hemorrhagic fever (is_implicated_in) | 1.37e-04 | 6 | 90 | 2 | DOID:12206 (is_implicated_in) | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.91e-04 | 7 | 90 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | corpus callosum anterior volume measurement | 2.32e-04 | 39 | 90 | 3 | EFO_0010295 | |
| Disease | Pulmonary Cystic Fibrosis | 3.27e-04 | 9 | 90 | 2 | C0392164 | |
| Disease | Fibrocystic Disease of Pancreas | 3.27e-04 | 9 | 90 | 2 | C1527396 | |
| Disease | Hematuria | 3.27e-04 | 9 | 90 | 2 | C0018965 | |
| Disease | myopathy (implicated_via_orthology) | 4.30e-04 | 48 | 90 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Systemic lupus erythematosus | 4.97e-04 | 11 | 90 | 2 | cv:C0024141 | |
| Disease | Shortened QT interval | 4.97e-04 | 11 | 90 | 2 | C0151879 | |
| Disease | Cystic Fibrosis | 4.97e-04 | 11 | 90 | 2 | C0010674 | |
| Disease | Prostatic Neoplasms | 5.95e-04 | 616 | 90 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.95e-04 | 616 | 90 | 8 | C0376358 | |
| Disease | acylcarnitine measurement | 6.28e-04 | 127 | 90 | 4 | EFO_0005059 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 9.41e-04 | 15 | 90 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.02e-03 | 670 | 90 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.07e-03 | 16 | 90 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | ulcerative colitis (is_implicated_in) | 1.21e-03 | 17 | 90 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | Autistic Disorder | 1.24e-03 | 261 | 90 | 5 | C0004352 | |
| Disease | lupus nephritis (is_implicated_in) | 1.36e-03 | 18 | 90 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | borna disease (biomarker_via_orthology) | 1.36e-03 | 18 | 90 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | spine bone size | 1.36e-03 | 18 | 90 | 2 | EFO_0004508 | |
| Disease | Colorectal Carcinoma | 1.38e-03 | 702 | 90 | 8 | C0009402 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.52e-03 | 19 | 90 | 2 | C0751884 | |
| Disease | alpha-tocopherol measurement | 1.69e-03 | 20 | 90 | 2 | EFO_0007898 | |
| Disease | Lung diseases | 1.77e-03 | 78 | 90 | 3 | C0024115 | |
| Disease | Arthrogryposis | 1.86e-03 | 21 | 90 | 2 | C0003886 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.90e-03 | 80 | 90 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Rheumatoid Arthritis | 2.01e-03 | 174 | 90 | 4 | C0003873 | |
| Disease | Bronchiectasis | 2.04e-03 | 22 | 90 | 2 | C0006267 | |
| Disease | Renal glomerular disease | 2.23e-03 | 23 | 90 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.23e-03 | 23 | 90 | 2 | C4521256 | |
| Disease | frailty measurement | 2.23e-03 | 23 | 90 | 2 | EFO_0009885 | |
| Disease | thalamus volume | 2.26e-03 | 85 | 90 | 3 | EFO_0006935 | |
| Disease | Anhedonia | 2.43e-03 | 24 | 90 | 2 | C0178417 | |
| Disease | Brugada Syndrome (disorder) | 2.43e-03 | 24 | 90 | 2 | C1142166 | |
| Disease | Intellectual Disability | 2.49e-03 | 447 | 90 | 6 | C3714756 | |
| Disease | cortical surface area measurement | CACNA2D1 ADAMTS3 MYO9B NAV3 NAV2 CCAR1 ADAMTS18 NCAM1 FRYL ADAMTSL3 SVEP1 | 2.60e-03 | 1345 | 90 | 11 | EFO_0010736 |
| Disease | Cardiac Arrhythmia | 2.64e-03 | 25 | 90 | 2 | C0003811 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 2.66e-03 | 90 | 90 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | macula measurement | 2.71e-03 | 189 | 90 | 4 | EFO_0008375 | |
| Disease | Hypertensive disease | 2.77e-03 | 190 | 90 | 4 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYKNTNSSNNFSRSC | 111 | Q9H0X4 | |
| ENNNDGSFQISYSCN | 116 | Q07001 | |
| GTFAAQENCFQYLQQ | 81 | Q6PJG6 | |
| QYSECFLANQSNFST | 1006 | Q4VNC0 | |
| QEASNNYSCLFDQIS | 896 | Q9Y6Y1 | |
| NVNDVCNFASRNDYS | 1506 | Q01955 | |
| QQAAAAAAALQQQYS | 71 | Q8IX12 | |
| ASQSCYQEINTQGNR | 526 | O43506 | |
| ENANALARYASICQQ | 166 | P05062 | |
| RFKANNNDSGEYTCQ | 91 | P12318 | |
| REYQTRQNQCFYNSS | 81 | P19652 | |
| RQNQCFYNSSYLNVQ | 86 | P19652 | |
| FLSSQVCFTQNNYIQ | 356 | Q9Y305 | |
| SSYNINDGVLQNSCF | 11 | O60706 | |
| QFNFSERASQTYNNP | 191 | Q9UI46 | |
| FSQKYQACRANLQST | 926 | Q9Y485 | |
| LSNNANYSCNQETIR | 411 | Q7L311 | |
| QQCFYQGFIRNDSSS | 141 | Q8TE60 | |
| NSLDFRAQQCAEYNS | 646 | Q8TE60 | |
| NINNVCNFASRNDYS | 1506 | P02462 | |
| LCGNFNQNQADDFTA | 561 | Q9HC84 | |
| FDYNSQQQLFQRTNA | 256 | Q8TB72 | |
| DNSYAFNQRSTCNGI | 6 | Q8NAB2 | |
| QAARYSVEKFNNCTN | 51 | O76096 | |
| CFYQQSNSVLACNRA | 56 | P31267 | |
| DLTQNVQYNQNRFLC | 1726 | Q4ZG55 | |
| NVQERSSAVYQCNAS | 421 | Q92823 | |
| FQQRCAQSAYCNTKQ | 376 | Q96QG7 | |
| YESQRQNLVQQACSS | 406 | Q6UWE0 | |
| SFNSFEQLCINYANE | 1596 | Q9UKN7 | |
| NQGYNFAEAVNFCTA | 596 | Q9BY66 | |
| AIATLAACYNNQQVF | 296 | P37268 | |
| RFNSSSVQCQNASYS | 736 | P51805 | |
| QYLANLAEQCSADNN | 2101 | Q8IVL0 | |
| AIANVFQNRDYQCDT | 1191 | O94915 | |
| RNFILDQCNVYNSGQ | 531 | Q1KMD3 | |
| DTGRYFCLAANDQNN | 491 | P32004 | |
| YQKTNQAAFNICANS | 311 | P49279 | |
| NYEQALQDASAACQN | 246 | Q1L5Z9 | |
| QNCSATDLFYQGNSQ | 2516 | Q9Y4D8 | |
| LYKQNSISFNACAAQ | 86 | P0C7N5 | |
| SENCSFQYQLRQTNQ | 6 | Q9UJ42 | |
| NSQTSSRACNFFNNV | 236 | Q13772 | |
| QCQQRNSHFEYQNTK | 616 | O15072 | |
| RQQYFKQNCSQHESS | 811 | P40189 | |
| NFNSLYTALCEQQTS | 331 | Q7RTS9 | |
| LARANTNNANANVAY | 1656 | Q13698 | |
| FEQLLNYNVSRANCN | 341 | P54289 | |
| CNINNVCNFASRNDY | 1521 | P29400 | |
| GDRNNSSCRNYNKQA | 291 | P17302 | |
| QEASNLLQESNCSQY | 221 | Q13617 | |
| NNHSLTDVCFSYRNN | 336 | O43462 | |
| CTNNIRCQFFSYATQ | 141 | P03952 | |
| FQLCNQNKSDCFYQT | 226 | P37088 | |
| ACRFNQVSCNQANYS | 281 | P37088 | |
| ATARQNFTYSCQNAA | 1641 | P25940 | |
| DVSFLSVNQNNYSRN | 466 | Q6P995 | |
| AEANQTCNNENAYLT | 526 | P22897 | |
| SNQCAQQCYNILGSF | 261 | Q12805 | |
| RQCNQCQNGFYNLQE | 671 | O75445 | |
| QVDQNCVRNSYDVFS | 181 | Q9P2Y5 | |
| YCVSAFQNTEFSNNR | 2131 | Q9NTG1 | |
| RQYLSNLADQCNSEN | 2201 | Q8IVL1 | |
| VGQYVNNCSNDRAAN | 226 | Q8NE22 | |
| NNCSNDRAANVCYQE | 231 | Q8NE22 | |
| RGSQAANIYCINFNQ | 226 | Q5MNZ6 | |
| NGYFIQNTCNNHFNA | 386 | Q4LDE5 | |
| SDSSIFVQSRNCNYQ | 351 | O15198 | |
| NSYENINNTARNNSD | 6 | Q01718 | |
| ENDFGNYNCTAVNRI | 481 | P13591 | |
| YNQKEFVSQSNCQQF | 316 | P48995 | |
| AFISNSRNYFSQCQA | 316 | A6PVC2 | |
| SRQYNHAAANQNSNA | 461 | Q92738 | |
| ACGEANNQNFQQRYH | 261 | Q6NZY4 | |
| VTYNDNCENAASQAS | 56 | Q86T26 | |
| QDALDNSQVFYTNCS | 526 | O94956 | |
| EFNATDALRCVNNYQ | 66 | O75663 | |
| NYYNASVSCCKQRNN | 151 | Q5TH74 | |
| FNEANNFYIRANSLQ | 56 | Q9UPY6 | |
| GNNQQSNCEYFVDSL | 26 | P68543 | |
| CLTALGSYNNYNNNC | 316 | P48066 | |
| NASNACIYNNADDIV | 456 | Q04864 | |
| VLNSFQDSNNSYARQ | 46 | Q8NAM6 | |
| YNCNQCGEAFSQKSN | 646 | Q6ZMW2 | |
| AQYCSEVHRQNTQQF | 636 | Q96QU8 | |
| DTQYSDQNRFNLCFE | 716 | O60602 | |
| QSHNACVNYANRNAT | 141 | Q8TD22 | |
| NKFNNNCYQDALVTS | 351 | P31645 | |
| NRYFCENCQSKQNAT | 266 | Q86UV5 | |
| CNFQLTQYQISHANQ | 16 | Q8N8C0 | |
| FDDNQCGNVFRNTQS | 241 | Q96RE9 | |
| EAFQSGQNNYSCTQC | 181 | P17021 | |
| SNNSQACAQFLEQYF | 221 | O14773 | |
| RAQQCSAYNDVQYQG | 131 | P82987 | |
| NQGYNFAEAVNFCTA | 606 | P41229 | |
| DNNSFEQFCINYCNE | 391 | O94832 | |
| NNSFEQFCINFANER | 546 | B2RTY4 | |
| SFEQFCINYANEQLQ | 531 | Q13459 |